4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-060551
Chief Executive Officer gave up 963 shares (to pay taxes)
- Chief Executive Officer acquired 3,646 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Quart Barry D · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-13 | Exercise or conversion : show line 1 in the form | +3,646 | 103,049 | D | ||
| 2021-10-13 | Shares withheld for taxes : show line 2 in the form | −963 | $10.55 | $10,160 | 102,086 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-13 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −3,646 | 43,750 | D |
| 2021-10-13 | Grant or award : show line 4 in the form Employee Stock Option (Right to Buy) | +390,834 | 390,834 | D |
| 2021-10-13 | Grant or award : show line 5 in the form Restricted Stock Units | +195,417 | 195,417 | D |
Loading xslF345X03/doc4.xml…